NCT05557279View on ClinicalTrials.gov

Urinary Microbiome Changes Following Administration of 500 mg of NDS-446 in Women With Dry OAB at 12 Weeks

PHASE4RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2025

Conditions
Overactive Bladder
Interventions
DRUG

500 mg NDS-446

All participants will receive 500 mg NDS-446 daily for 12 weeks following a baseline assessment

Trial Locations (1)

60153

RECRUITING

Loyola Medical Center, Maywood

All Listed Sponsors
lead

Loyola University

OTHER